tirzepatide hi Associated with Lower POAG, OHT Risk Compared with Other GLP-1 Drugs 22% body weight Tirzepatide for Medical Weight Loss

The post presents this as pathway-level context for a provider conversation, not as something that predicts whether a medication will work for you

Here are some of the most notable findings related to intranasal PT-141 to date: Safarinejad et al

Pharmacology vs

Introduced in 2021, these injections address obesity as a chronic metabolic condition, not just a problem of willpower or temporary lifestyle changes

Nutrition: Are you nourishing your bodynot just eating less or more, but meeting your energy and micronutrient needs

Population pharmacokinetic studies involving over 5,800 participants across 19 clinical trials found a clearance rate of just 0.0329 liters per hour per 70 kilograms of body weight